1. MARKETS
  2. SECTOR : BANKING & FINANCE
  3. INDUSTRY : FINANCIAL CONGLOMERATES
  4. ALLURION TECHNOLOGIES INC
Allurion Technologies Inc
XNYS: ALUR

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Allurion Tech Inc is on 14 May 2026 for the purpose of Allurion Technologies Inc First Quarter Earnings Results for 2026 See details


Insider Trading disclosures for Allurion Tech Inc

The latest disclosure was made by Ojas Buch in Allurion Tech Inc where a trade of 2,047 Common Stock done at an average price of $1.6 was reported to US exchanges on Dec. 31, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ojas Buch Chief Operating Officer 31 Dec 2025 2,047 10,223 - 1.6 3,173 Common Stock
Brendan M. Gibbons Chief Legal Officer 31 Dec 2025 1,862 10,408 - 1.5 2,886 Common Stock
Michael R. Davin Director Sale of securities on an exchange or to another person at price $ 1.48 per share. 03 Oct 2025 1,606 1,606 - 1.5 2,377 Common Stock
Michael R. Davin Director Gift of securities by or to the insider at price $ 0.00 per share. 03 Oct 2025 2,608 3,212 - 0 Common Stock
Michael R. Davin Director Gift of securities by or to the insider at price $ 0.00 per share. 03 Oct 2025 2,608 1,206 - 0 Common Stock
Michael R. Davin Director Gift of securities by or to the insider at price $ 0.00 per share. 03 Oct 2025 604 604 - 0 Common Stock
Michael R. Davin Director Gift of securities by or to the insider at price $ 0.00 per share. 03 Oct 2025 604 3,814 - 0 Common Stock
Michael R. Davin Director Sale of securities on an exchange or to another person at price $ 1.58 per share. 03 Oct 2025 1,606 0 - 1.6 2,541 Common Stock
Shantanu Gaur Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 3.06 per share. 19 May 2025 8,000 16,000 - 3.1 24,484 Common Stock
Shantanu Gaur Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 3.35 per share. 28 Mar 2025 8,000 8,000 - 3.4 26,800 Common Stock
Keith B. Johns Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2024 326,086 326,086 - 0 Common Stock
Ojas Buch Chief Operating Officer 08 Nov 2024 306,749 306,749 - 0 Common Stock
Ojas Buch Chief Operating Officer 03 Jun 2024 306,749 306,749 - - Stock Option (Right to Buy)
Shantanu Gaur Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2024 1,298,701 1,298,701 - - Stock Option (Right to Buy)
Shantanu Gaur Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2024 1,428,571 1,428,571 - - Stock Option (Right to Buy)
Ram Chuttani Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2024 204,082 204,082 - - Stock Option (Right to Buy)
Alberti-Perez Milena Director 11 Mar 2024 75,000 75,000 - 0 Common Stock
Jacques Claude Chardon Benoit Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Dec 2023 18,741 20,377 - - Stock Option (Right to Buy)
Chardon Benoit Jacques Claude Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.17 per share. 12 Dec 2023 23,939 155,382 - 1.2 28,009 Common Stock
Jacques Claude Chardon Benoit Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Dec 2023 97,799 0 - - Stock Option (Right to Buy)
Benoit Jacques Claude Chardon Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Dec 2023 23,939 510 - - Stock Option (Right to Buy)
Benoit Jacques Claude Chardon Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.88 per share. 12 Dec 2023 18,741 199,183 - 1.9 35,233 Common Stock
Jacques Claude Chardon Benoit Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.13 per share. 12 Dec 2023 97,799 131,443 - 1.1 110,513 Common Stock
Chardon Benoit Jacques Claude Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.95 per share. 12 Dec 2023 25,060 180,442 - 1.0 23,807 Common Stock
Chardon Jacques Claude Benoit Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Dec 2023 25,060 4,279 - - Stock Option (Right to Buy)
Omar Ishrak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Oct 2023 45,235 45,235 - 0 Common Stock
Douglas Larson Hudson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Oct 2023 45,235 45,235 - 0 Common Stock
Krishna K. Gupta Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Oct 2023 45,235 1,381,107 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters